Baynes Roy D. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$6.05M

Insider Activity of Baynes Roy D.

According to the SEC Form 4 filings, Baynes Roy D., being in a position of

  1. director at Natera, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12780 shares for $2.81M,
    over all time since 2020-08-07, has bought 0 shares, and sold 51310 shares for $8.32M.

Biography of Baynes Roy D.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,357,8897100

Comparison of Insiders on Amount of Buys and Sells

2026-06-12SaleTravere Therapeutics, Inc.
TVTX
director
4,500
0.0046%
$50.00$225,000+10.22%
2026-05-05SaleTravere Therapeutics, Inc.
TVTX
director
4,500
0.005%
$46.65$209,925+25.7%
2026-05-01SaleTravere Therapeutics, Inc.
TVTX
director
9,750
0.0106%
$44.22$431,145+27.55%
2026-04-14SaleTravere Therapeutics, Inc.
TVTX
director
32,750
0.0466%
$41.29$1.35M+31.88%
2026-04-06SaleTravere Therapeutics, Inc.
TVTX
director
10,000
0.0112%
$33.00$330,000+73.26%
2025-11-20SaleNatera, Inc.
NTRA
director
7,668
0.0055%
$223.08$1.71M+4.38%
2025-11-19SaleNatera, Inc.
NTRA
director
5,112
0.0036%
$215.00$1.1M+7.81%
2025-02-06SaleTravere Therapeutics, Inc.
TVTX
director
10,000
0.0119%
$22.00$220,000-3.52%
2025-01-23SaleTravere Therapeutics, Inc.
TVTX
director
16,000
0.0178%
$20.00$320,000+0.1%
2024-11-15SaleNatera, Inc.
NTRA
director
37,230
0.1045%
$146.11$5.44M+11.61%
2020-08-07SaleNatera, Inc.
NTRA
director
1,300
0.0016%
$53.47$69,513+89.52%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.